Newcastle-based BioTech company that aims to disrupt the market for PCR laboratory tests
InvenireX has raised €2.9M across 2 funding rounds from 5 investors, most recently a Seed round in Nov 2025. Based in Newcastle upon Tyne, UK; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-11-18 | Seed | €2.3M | Angel Investors,Cambridge Technology Capital,DSW Ventures,Innovate UK,XTX Ventures | View deal → |
| 2024-03-19 | Other | €585k | DSW Ventures,XTX Ventures | View deal → |
